Effect of Nucleos(t)ide analogue combined with traditional Chinese medicine on liver fibrosis in chr

来源 :2014年APASL专题会议暨第四届乙型病毒性肝炎专题会议 | 被引量 : 0次 | 上传用户:xiaotang111
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
BACKGROUND & AIMS:Traditional Chinese medicine(TCM),Biejiaruangan Compound(BJRGC),containing Carapax trionycis,Cordyceps sinensis and other 9 herbs has been used to treat liver fibrosis for almost two decades in China.
其他文献
Background:Gamma delta T cells play an important role in infectious,autoimmune,or neoplastic diseases.Our previous studies have found that the proportion of gamma delta T cells increased with abnormal
会议
Background:To study the function of TH1/TH2 types cell in chronic hepatitis B(CHB)patients during the treatment by autologous cytokine-induced kill cells combined with nucleoside(acid) analogues of an
会议
Background:5 %-10 %Hepatitis B vaccinees produce an inadequate neutralizing antibody response following receipt of the standard vaccination regime.Genetic predisposition has been discovered to be one
会议
Background:Genetic studies have been conducted to investigate host susceptibility of the hepatitis B virus(HBV) infection;SNPs in the HLA region(6p21) were mostly reported associated with the disease
会议
Background:We investigated whether the concept of virologic breakthrough suggested by current guidelines or literatures is appropriate for treatment with entecavir(ETV) in the era of sensitive HBV DNA
会议
Background:An important goal in the treatment of chronic hepatitis B virus(HBV) infection is to prevent hepatocellular carcinoma and liver cirrhosis by suppressing HBV replication.
会议
Background:The EFFORT study have concluded that adjusting treatment strategy is recommended for suboptimal virological responders to telbivudine(LdT) at week 24,adding on adefovir(ADV) can benefit the
会议
Background:This trial is to assess the efficacy and safety of Polyethylene Glycol thymosin alpha1(PEG-Tα1),a new long immunomodulator(Category 1.1 of Chemical Drugs) being developed from Hansoh Pharma
会议
Background:To investigate the course and efficacy of sequential PEG-IFN treatment for poor effect of HBeAg positive chronic hepatitis B patients treated with nucleos(t)ide analogue.
会议
Background:Discuss differences between early cirrhosis and no cirrhosis patients in chronic hepatitis B(CHB)patients at HBV genotypes and nontraumatic indexs commonly used in clinical.
会议